32 Spam-Free Article(s) Found
Article Searches
The Zacks Analyst Blog Highlights: Johnson & Johnson, Merck & Co, Novartis, PayPal and IBM http://www.zacks.com/stock/news/858931/the-zacks-analyst-blog-highlights-johnson-johnson-merck-co-novartis-paypal-and-ibm?cid=CS-ZC-FT-press_releases-858931 Apr 07, 2020 - The Zacks Analyst Blog Highlights: Johnson & Johnson, Merck & Co, Novartis, PayPal and IBM
Tomtom NV 2020 Q1 - Results - Earnings Call Presentation https://seekingalpha.com/article/4337652-tomtom-nv-2020-q1-results-earnings-call-presentation?source=feed_all_articles Apr 15, 2020 - The following slide deck was published by Tomtom NV in conjunction with their 2020 Q1 earnings call.
Bausch (BHC) Starts Study on Virazole for Coronavirus Infection http://www.zacks.com/stock/news/870392/bausch-bhc-starts-study-on-virazole-for-coronavirus-infection?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-870392 Apr 14, 2020 - Bausch (BHC) begins a clinical study on Virazole in combination with standard-of-care therapy to treat adults with respiratory distress due to COVID-19 in Canada.
Schlumberger NV (SLB) Q1 2020 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2020/04/17/schlumberger-nv-slb-q1-2020-earnings-call-transcri.aspx?source=iedfolrf0000001 Apr 17, 2020 - SLB earnings call for the period ending March 31, 2020.
Why Earnings Season Could Be Great for Novartis (NVS) http://www.zacks.com/stock/news/882027/why-earnings-season-could-be-great-for-novartis-nvs?cid=CS-ZC-FT-tale_of_the_tape|earnings_surprise-882027 Apr 21, 2020 - Novartis (NVS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Novartis To Initiate Hydroxychloroquine Study for Coronavirus http://www.zacks.com/stock/news/880449/novartis-to-initiate-hydroxychloroquine-study-for-coronavirus?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-880449 Apr 20, 2020 - Novartis (NVS) announces FDA's approval to evaluate hydroxychloroquine in hospitalized patients with COVID-19 in a late-stage study. The company is evaluating several of its drugs to treat COVID-19.
What's The Best Biotech Stock to Buy for Treating Sickle Cell Disease? https://www.fool.com/investing/2020/04/22/whats-the-best-biotech-stock-to-buy-for-treating-s.aspx?source=iedfolrf0000001 Apr 22, 2020 - Targeted therapies for treating sickle cell disease are finally here after a 60-year wait.
Can Lilly (LLY) Deliver a Beat in Coronavirus-Hit Q1 Earnings? http://www.zacks.com/stock/news/882090/can-lilly-lly-deliver-a-beat-in-coronavirus-hit-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-882090 Apr 21, 2020 - Investor focus is likely to be on the impact of the coronavirus outbreak on Lilly's (LLY) performance when it reports first-quarter results.
Novartis AG (NVS) CEO Vasant Narasimhan on Q1 2020 Results - Earnings Call Transcript https://seekingalpha.com/article/4340622-novartis-ag-nvs-ceo-vasant-narasimhan-on-q1-2020-results-earnings-call-transcript?source=feed_sector_healthcare Apr 28, 2020 - Novartis AG (NYSE:NVS) Q1 2020 Earnings Conference Call April 28, 2020, 07:00 ET Company Participants Samir Shah - Global Head, IR Vasant Narasimhan - CEO Marie-France Tschudin - President, Novartis P
Telenet Group Holding NV 2020 Q1 - Results - Earnings Call Presentation https://seekingalpha.com/article/4341477-telenet-group-holding-nv-2020-q1-results-earnings-call-presentation?source=feed_all_articles Apr 30, 2020 - The following slide deck was published by Telenet Group Holding NV in conjunction with their 2020 Q1 earnings call.

Pages: 1234

Page 1>